Slides: PCSK9 inhibition & CV events: Review of recent and upcoming hard endpoint outcome trialsAug. 26, 2017 - Barcelona, Spain - Peter Sever, MD London, United Kingdom - PACE-CME symposium, ESC 2017
The slides are prepared and presented by the speaker during a CME accredited symposium: PCSK9 inhibition & Cardiovascular Outcomes: Review of lipid targets and treatment strategies held at ESC 2017 in Barcelona. The slides are an educational service to registered PACE members only. PACE is not responsible for the content, opinions expressed in the slides.